What is the recommended dose of lisinopril?

Lisinopril Dosing Recommendations

For hypertension, start lisinopril at 10 mg once daily and titrate to a target dose of 20-40 mg once daily based on blood pressure response, with a maximum of 80 mg daily if needed. 1

Dosing by Indication

Hypertension (Adults)

• Initial dose: 10 mg once daily 1
• Usual maintenance range: 20-40 mg once daily 1
• Maximum dose: 80 mg daily (though doses above 40 mg provide minimal additional benefit) 1
• With concurrent diuretic use: Start at 5 mg once daily 1

The FDA label clearly establishes these parameters, and clinical trials demonstrate that most patients achieve adequate blood pressure control within this range 1. If blood pressure remains uncontrolled on lisinopril monotherapy, adding a low-dose diuretic (e.g., hydrochlorothiazide 12.5 mg) is more effective than pushing lisinopril to maximum doses 1.

Heart Failure

• Initial dose: 5 mg once daily (when used with diuretics and typically digitalis) 1
• Initial dose with hyponatremia (Na <130 mEq/L): 2.5 mg once daily 1
• Target dose: Titrate to maximum of 40 mg once daily as tolerated 1
• Titration strategy: The 2022 AHA/ACC/HFSA Heart Failure Guideline emphasizes uptitrating to target doses shown effective in randomized controlled trials, with the target for lisinopril being 20-40 mg once daily 2

Key principle: Even if symptoms improve at lower doses, continue titrating toward target doses unless not tolerated, as this approach was used in pivotal trials demonstrating mortality benefit 2.

Acute Myocardial Infarction

• Initial dose (within 24 hours): 5 mg orally 1
• Dosing schedule: 5 mg after 24 hours, then 10 mg after 48 hours, then 10 mg once daily 1
• Duration: Continue for at least 6 weeks 1
• Low systolic BP (≤120 mmHg and >100 mmHg): Start at 2.5 mg 1
• If hypotension develops (SBP ≤100 mmHg): Reduce to 5 mg daily maintenance with temporary reductions to 2.5 mg if needed 1
• Withdraw if: Prolonged hypotension (SBP <90 mmHg for >1 hour) 1

Pediatric Patients (≥6 years with hypertension)

• Initial dose: 0.07 mg/kg once daily (up to 5 mg maximum) 1
• Maximum dose: 0.61 mg/kg once daily (up to 40 mg) 1
• Contraindication: Not recommended in children <6 years or with GFR <30 mL/min/1.73m² 1

Renal Impairment Adjustments

Critical dosing modifications are required based on creatinine clearance:

• CrCl >30 mL/min: No adjustment needed 1
• CrCl 10-30 mL/min: Reduce initial dose by 50%:
  • Hypertension: 5 mg once daily 1
  • Heart failure: 2.5 mg once daily 1
  • Acute MI: 2.5 mg once daily 1
  • Titrate to maximum 40 mg daily as tolerated 1
• CrCl <10 mL/min or hemodialysis: 2.5 mg once daily 1

Important Clinical Considerations

Once-Daily vs Twice-Daily Dosing Controversy

While the FDA label recommends once-daily dosing 1, recent real-world evidence challenges the manufacturer's suggestion that twice-daily dosing may be superior when once-daily is insufficient. A 2017 study found twice-daily lisinopril 20 mg (total 40 mg) produced greater systolic BP reduction (10.2 mmHg more) compared to once-daily 40 mg 3. However, a larger 2020 study found no BP differences between once-daily and twice-daily regimens 4, and notably, twice-daily dosing was associated with increased angioedema risk (OR 2.27) 4.

Practical recommendation: Prioritize once-daily dosing for adherence. If BP control is inadequate at maximum once-daily doses, add a second antihypertensive agent rather than splitting to twice-daily 1.

Titration Frequency

For heart failure patients, the 2022 AHA/ACC/HFSA guideline suggests titration can occur as frequently as every 1-2 weeks depending on symptoms, vital signs, and laboratory findings 2. This aggressive approach aims to reach target doses that demonstrated mortality benefit in clinical trials.

Common Pitfalls

• Underdosing: Many patients remain on subtherapeutic doses. Research shows higher doses (40-60 mg) provide additional renoprotection in diabetic nephropathy 5, though 60 mg offers no advantage over 40 mg 5
• Ignoring renal function: Failure to adjust for renal impairment increases risk of hyperkalemia and acute kidney injury
• Premature discontinuation after hypotension: Initial hypotension after the first dose does not preclude careful subsequent titration 1

Monitoring Parameters

• Blood pressure response (target <140/90 mmHg for most patients)
• Serum creatinine and potassium (especially within 1-2 weeks of initiation or dose changes)
• Signs of angioedema (more common with twice-daily dosing 4)